IOL Chemicals & Pharmaceuticals Ltd. (IN:IOLCP)

:IOLCP

IOLCP

IOL Chemicals & Pharmaceuticals Ltd.

RESEARCH TOOLSreports

Want to see IN:IOLCP full AI Analyst Report?

IOL Chemicals & Pharmaceuticals Ltd. (IOLCP) Price & Analysis

2 Followers

IOLCP Stock Chart & Stats

₹84.09

-₹4.90(-1.13%)

At close: Jan 08 4:00 PM EST

₹84.09

-₹4.90(-1.13%)

Day’s Range― - ―

52-Week Range₹60.55 - ₹126.60

Previous CloseN/A

Volume410.76K

Average Volume (3M)113.78K

Market Cap

₹26.12B

Enterprise Value₹28.41B

Total Cash (Recent Filing)₹1.79B

Total Debt (Recent Filing)₹1.59B

Price to Earnings (P/E)29.4

Beta1.68

Next Earnings

Jun 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.97%

Share Statistics

EPS (TTM)1.10

Shares Outstanding293,527,500

10 Day Avg. Volume248,884

30 Day Avg. Volume113,785

Financial Highlights & Ratios

PEG Ratio-3.72

Price to Book (P/B)5.55

Price to Sales (P/S)4.53

P/FCF Ratio-268.11

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)5.2

Revenue Forecast (FY)₹25.89B

Bulls Say, Bears Say

Bulls Say

Strong Balance SheetA healthy equity ratio and low leverage provide durable financial flexibility, allowing the firm to fund capital expenditure, absorb demand shocks, and access credit without stressing liquidity. This structural strength supports continuity of operations and strategic investments over months.

Positive Operating Cash FlowSustained positive operating cash flow indicates the core pharmaceuticals and chemicals businesses generate cash from operations, supporting working capital and routine reinvestment. Over 2-6 months this underpins resilience to cyclical downturns and funds ongoing operations.

Earnings Per Share GrowthStrong EPS growth reflects improving profitability or operational leverage, enabling internal reinvestment, debt reduction, or shareholder returns. Sustained EPS expansion over several quarters signals better unit economics and management execution on core product lines.

Bears Say

Declining Free Cash FlowDeclining free cash flow restricts the company’s ability to invest in capacity, R&D, or to strengthen the balance sheet without external funding. Over a multi-month horizon this can constrain growth initiatives and increase reliance on financing for strategic projects.

Revenue And Margin PressureA recent revenue decline coupled with compressing EBIT/EBITDA margins signals structural demand or pricing pressure or rising input costs. Persisting top-line and margin weakness erodes reinvestment capacity and profitability, affecting long-term competitiveness.

Reduced Return On EquityA falling ROE indicates lower efficiency in converting equity into returns, potentially from weaker margins or higher equity base. Persistently lower ROE reduces shareholder wealth creation and may point to the need for strategic changes to restore capital efficiency.

IOL Chemicals & Pharmaceuticals Ltd. News

IOL Chemicals & Pharmaceuticals Promoter Group Ups Stake Via Market Purchase

IOL Chemicals & Pharmaceuticals Ltd. ( ($IN:IOLCP) ) has provided an announcement. IOL Chemicals & Pharmaceuticals Ltd. disclosed...

1M ago

IOLCP

IOL Chemicals & Pharmaceuticals Promoter Group Raises Stake via Market Purchase

An update from IOL Chemicals & Pharmaceuticals Ltd. ( ($IN:IOLCP) ) is now available. IOL Chemicals and Pharmaceuticals...

1M ago

IOLCP

IOLCP FAQ

What was IOL Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?

IOL Chemicals & Pharmaceuticals Ltd. lowest stock price was ₹60.55 and its highest was ₹126.60 in the past 12 months.

What is IOL Chemicals & Pharmaceuticals Ltd.’s market cap?

IOL Chemicals & Pharmaceuticals Ltd.’s market cap is ₹26.12B.

When is IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?

IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 36 days.

How were IOL Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?

IOL Chemicals & Pharmaceuticals Ltd. released its earnings results on Feb 11, 2026. The company reported ₹1.1 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.1.

Is IOL Chemicals & Pharmaceuticals Ltd. overvalued?

According to Wall Street analysts IOL Chemicals & Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does IOL Chemicals & Pharmaceuticals Ltd. pay dividends?

IOL Chemicals & Pharmaceuticals Ltd. pays a Annually dividend of ₹0.8 which represents an annual dividend yield of 0.97%. See more information on IOL Chemicals & Pharmaceuticals Ltd. dividends here

What is IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate?

IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does IOL Chemicals & Pharmaceuticals Ltd. have?

IOL Chemicals & Pharmaceuticals Ltd. has 293,527,500 shares outstanding.

What happened to IOL Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?

IOL Chemicals & Pharmaceuticals Ltd. reported an EPS of ₹1.1 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.688%.

Which hedge fund is a major shareholder of IOL Chemicals & Pharmaceuticals Ltd.?

Currently, no hedge funds are holding shares in IN:IOLCP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

IOL Chemicals & Pharmaceuticals Ltd.

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. Its products are used for treatments, which include anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana, India.